Previous 10 | Next 10 |
Summary Silver Ring Value Partners provides investment advisory services. The Company offers portfolio management, financial planning, and trading services. Silver Ring Value Partners serves investors in the State of Massachusetts. At the end of June 2022 the portfolio was very at...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are plenty of stocks under $10 out there, but choosing a good one isn’t easy. Investors who survived 2022’s bear market rout either are cash rich or hold energy stocks. In the former scenario, portfoli...
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of L...
Royalty Pharma has agreed to acquire a royalty interest in Trelegy treatment from Innoviva, Inc. and Theravance Biopharma, Inc. for $1.3 billion in an upfront cash payment. The company is expecting this deal to add a minimum of $200 million to the adjusted non-GAAP cash receipt of RPR...
Innoviva press release ( NASDAQ: INVA ): Q2 GAAP EPS of $0.05. Revenue of $108.22M (+7.4% Y/Y). Royalties increased by 7% to $111.7 million in the second quarter of 2022, compared to the same quarter in 2021 Entered into definitive merger agreement to acquire all o...
Royalties increased by 7% to $111.7 million in the second quarter of 2022, compared to the same quarter in 2021 Completed acquisition of the remaining approximately 40% of Entasis Therapeutics at a price of $2.20 per share for a consideration of $42 million in July 2022 ...
Shares of Innoviva ( NASDAQ: INVA ) fell as much as 2.4% to $14.37 in Wednesday trading after Goldman Sachs initiated the company with a neutral rating. Goldman Sachs analyst Chris Shibutani gave INVA stock a price target of $16, implying a 8.7% upside to INVA's last clo...
Innoviva to receive approximately $282 million in cash up front with potential $50 million milestone payment Innoviva to retain TRC’s full ownership in attractive private investments Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding c...
Further diversifies Royalty Pharma’s portfolio with market-leading respiratory therapy Expected to significantly add to long-term Adjusted Cash Receipts growth ( 1) ( non-GAAP) NEW YORK, July 13, 2022 (GLOBE NEWSWIRE) -- Royalty Pharma pl...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips In a development that’s garnering attention in the healthcare sector, La Jolla Pharmaceutical (NASDAQ: LJPC ) has reportedly consented to be acquired by Innovia (NASDAQ: INVA ). As a result, LJPC stock ...
News, Short Squeeze, Breakout and More Instantly...
Innoviva, Inc. (Nasdaq: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics (“IST”), and a portfolio of strate...